IAGG World Congress, July 23-26
Symposia
- Understanding and Communicating Vaccine Technologies
Leonard Friedland and Jeffrey Stoddard - New Insights Into Immunologic Mechanisms of Protection Through Vaccination in Older Adults
Janet McElhaney, George Kuchel, Arne Akbar
Industry-Supported Symposia
- Expanding Perspectives on Vaccine-Preventable Disease in Older Adult Populations
Pfizer, Inc. - Emergent Issues in Pneumococcal Disease Among Aging Populations
Pfizer, Inc.
Innovation Theater
- Influenza in Older Adults—A Vulnerable Population
Stefan Gravenstein, Janet E. McElhaney
Papers
- Norovirus Gastroenteritis Is an Important Cause of Nosocomial Infections in Germany
Frank Kowalzik, Daniela Zöller, Harald Binder, Ralf Clemens, Thomas Verstraeten, Fred Zepp - Increased Incidence of Medically-Attended Norovirus Among Older Adults With Chronic Disease
Mark Schmidt, Kayoko Shioda, Allison Naleway, Christianne Biggs, Aron Hall
Posters
- Session 575
- Antibody Responses to 23-Valent Pneumococcal Polysaccharide Vaccine After Primary and Revaccination
Kenji Kawakami, Hiroyuki Kishino, Shinichi Kanazu, Nobuhito Toshimuzu, Ruroiko Yokokawa, Kenichi Takahashi, Mel Kohn, Luwey Musey - Responses to 23-Valent Pnuemococcal Polysaccharide Vaccine in Adults 70-79 With Chronic Diseases
Kenji Kawakami, Hiroyuki Kishino, Shinichi Kanazu, Nobuhito Toshimuzu, Ruroiko Yokokawa, Kenichi Takahashi, Mel Kohn, Luwey Musey - The Need for Better Vaccines for Older Adults
William Schaffner, Stefan Gravenstein - Zoster Vaccine Live: Review of Postmarketing Safety by Decade of Life
English Willis, Meredith Woodward, Elizabeth Brown, Zoran Popmihajlov - Effectiveness of Live Zoster Vaccine in Preventing Postherpetic Neuralgia (PHN)
Roger Baxter, Joan Bartlett, Bruce Fireman, Morgan Marks, John Hansen, Laurie Aukes, Eddy Bresnitz, Patricia Saddier - Disparities in Influenza Immunization Status Among Post-Acute and Long-Term Care Patients/Residents
Colene Byrne, Lauren Palmer, Daniel Barch, Nicole Jarrett, Amy Helburn, Holly Neumann, Laura Smith - Immune Risk Profile (IRP) and Morbidity Phenotype of Independent Oldest Old
Marcelo Caldeira, Milena Brunialti, Reinaldo Salomão, Clineu Mello, Almada Filho, Maysa Cendoroglo
- Antibody Responses to 23-Valent Pneumococcal Polysaccharide Vaccine After Primary and Revaccination
- Session 900
- Using Educational Interventions to Affect Provider Practices in Immunizations
Debra Hawks - UN Agenda 2030: Adult Vaccinations as a Public Health Interest for Healthy Ageing
Cynthia Stuen, Jane Barratt, Ken Bluestone, Erica Dhar
- Using Educational Interventions to Affect Provider Practices in Immunizations
- Session LB910
- Impact on Cardiorespiratory Outcomes of High vs Standard Dose Influenza Vaccine in U.S. Nursing Homes
Stefan Gravenstein, Jessica Ogarek, Monica Taljaard, Lisa Han, H. Edward Davidson, Pedro Gozalo, Vincent Mor - Influenza-Induced Muscle Degradation: A Pathway to Age-Associated Disability
Jenna Bartley, Spencer Keilich, George Kuchel, Laura Haynes - Production of TNF Ex Vivo Is Predictive of an Immune Response to Flu Vaccination in Elderly Subjects
-
Frederic Bloch, Benedicte Charmeteau, Michael Tovey, Jean-François Meritet, Corinne Desaint, Odile Launay, Pierre Lebon
- Impact on Cardiorespiratory Outcomes of High vs Standard Dose Influenza Vaccine in U.S. Nursing Homes
- Session LB3720
- Cost of Diagnosed Herpes Zoster Complications in Patients Age ≥50 Years: A U.S. Claims Data Analysis
Debora Rausch, Myron Levin, Juliana Meyers, Sean Candrilli, Songkai Yan, Girishanthy Krishnarajah, Brandon Patterson
- Cost of Diagnosed Herpes Zoster Complications in Patients Age ≥50 Years: A U.S. Claims Data Analysis
- Session LB4585